Current perspectives in stem cell research for knee cartilage repair

Stem Cells and Cloning: Advances and Applications

Volumn 7, Issue 1, 2014, Pages

  Orth, Patrick ^a   Rey Rico, Ana ^a   Venkatesan, Jagadeesh K ^a   Madry, Henning ^a   Cucchiarini, Magali ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Cartilage repair; Clinical trials; Focal defects; Knee; Osteoarthritis; Stem cells

Indexed keywords

AGGRECAN; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; COLLAGEN TYPE 2; CORTICOSTEROID; FIBRIN; FIBRIN GLUE; HYALURONIC ACID; HYDROXYAPATITE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OSTEOGENIC PROTEIN 1; PROTEIN BCL XL; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN RECEPTOR 1; VIRUS VECTOR;

ADIPOSE DERIVED MESENCHYMAL STEM CELL; ANTIANGIOGENIC ACTIVITY; ARTICULAR CARTILAGE; BIOCOMPATIBILITY; BONE GRAFT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARCINOGENESIS; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL MANIPULATION; CERAMICS; CHONDROGENESIS; CLINICAL PROTOCOL; CONSERVATIVE TREATMENT; DETERIORATION; EMBRYONIC STEM CELL; GENE TRANSFER; GRAFT REJECTION; HUMAN; HYALINE CARTILAGE; HYDROGEL; KNEE CARTILAGE REPAIR; KNEE FUNCTION; KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE; KNEE SURGERY; LENGTH OF STAY; LYSHOLM SCORE; MESENCHYMAL STEM CELL; NEUROLOGICAL COMPLICATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; OSTEOARTHRITIS; PAIN; PATHOPHYSIOLOGY; PATIENT MONITORING; PATIENT SAFETY; PERIPHERAL BLOOD MARROW DERIVED MESENCHYMAL STEM CELL; PLASTIC SURGERY; PLURIPOTENT STEM CELL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; REVIEW; SHORT FORM 36; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; SYNOVIAL DERIVED MESENCHYMAL STEM CELL; TERATOMA; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; UMBILICAL CORD BLOOD MESENCHYMAL STEM CELL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

EID: 84892621722     PISSN: None     EISSN: 11786957     Source Type: Journal    
DOI: 10.2147/SCCAA.S42880     Document Type: Review

References (241)

1. O'Driscoll S W. The healing and regeneration of articular cartilage. J Bone Joint Surg Am. 1998;80(12):1795-1812.
2. Cucchiarini M, Madry H. Gene therapy for cartilage defects. J Gene Med. 2005;7(12):1495-1509.
3. Hunziker EB, Michel M, Studer D. Ultrastructure of adult human articular cartilage matrix after cryotechnical processing. Microsc Res Tech. 1997;37(4):271-284.
4. Burr DB. Anatomy and physiology of the mineralized tissues: role in the pathogenesis of osteoarthrosis. Osteoarthritis Cartilage. 2004; 12 Suppl A:S20-S30.
5. Orth P, Cucchiarini M, Kohn D, Madry H. Alterations of the subchondral bone in osteochondral repair - translational data and clinical evidence. Eur Cell Mater. 2013;25:299-316.
6. Madry H, Cucchiarini M, Orth P. Gene therapy for cartilage repair. Cartilage. 2011;2(3):201-225.
7. Hunziker EB. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage. 2002;10(6):432-463.
8. Furukawa T, Eyre DR, Koide S, Glimcher MJ. Biochemical studies on repair cartilage resurfacing experimental defects in the rabbit knee. J Bone Joint Surg Am. 1980;62(1):79-89.
9. Franke O, Durst K, Maier V, et al. Mechanical properties of hyaline and repair cartilage studied by nanoindentation. Acta Biomater. 2007;3(6): 873-881.
10. Caplan AI, Elyaderani M, Mochizuki Y, Wakitani S, Goldberg VM. Principles of cartilage repair and regeneration. Clin Orthop Relat Res. 1997;342:254-269.
11. Caplan AI, Goldberg VM. Principles of tissue engineered regeneration of skeletal tissues. Clin Orthop Relat Res. 1999;367 Suppl: S12-S16.
12. Hunziker EB, Rosenberg LC. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am. 1996;78(5):721-733.
13. Jackson DW, Lalor PA, Aberman HM, Simon TM. Spontaneous repair of full-thickness defects of articular cartilage in a goat model. A preliminary study. J Bone Joint Surg Am. 2001;83A(1):53-64.
14. Shapiro F, Koide S, Glimcher MJ. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1993;75(4):532-553.
15. Mienaltowski MJ, Huang L, Frisbie DD, et al. Transcriptional profl-ing differences for articular cartilage and repair tissue in equine joint surface lesions. BMC Med Genomics. 2009;2:60-73.
16. Strauss EJ, Goodrich LR, Chen CT, Hidaka C, Nixon AJ. Biochemical and biomechanical properties of lesion and adjacent articular cartilage after chondral defect repair in an equine model. Am J Sports Med. 2005;33(11):1647-1653.
17. Anraku Y, Mizuta H, Sei A, et al. Analyses of early events during chondrogenic repair in rat full-thickness articular cartilage defects. J Bone Miner Metab. 2009;27(3):272-286.
18. Anraku Y, Mizuta H, Sei A, et al. The chondrogenic repair response of undifferentiated mesenchymal cells in rat full-thickness articular cartilage defects. Osteoarthritis Cartilage. 2008;16(8):961-964.
19. Gomoll AH, Farr J, Gillogly SD, Kercher J, Minas T. Surgical management of articular cartilage defects of the knee. J Bone Joint Surg Am. 2010;92(14):2470-2490.
20. Sanchez C, Pesesse L, Gabay O, et al. Regulation of subchondral bone osteoblast metabolism by cyclic compression. Arthritis Rheum. 2012;64(4):1193-1203.
21. Henrotin Y, Pesesse L, Sanchez C. Subchondral bone and osteoarthritis: biological and cellular aspects. Osteoporos Int. 2012;23 Suppl 8: S847-S851.
22. Pridie KH. A method of resurfacing knee joints. Proceedings of the British Orthopaedic Association. J Bone Joint Surg Br. 1959;41: 618.
23. Steadman JR, Rodkey WG, Rodrigo JJ. Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res. 2001;391 Suppl:S362-S369.
24. Johnson LL. Arthroscopic abrasion arthroplasty historical and pathologic perspective: present status. Arthroscopy. 1986;2(1):54-69.
25. Gomoll AH, Madry H, Knutsen G, et al. The subchondral bone in articular cartilage repair: current problems in the surgical management. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):434-447.
26. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chon-drocyte transplantation. N Engl J Med. 1994;331(14):889-895.
27. Hangody L, Kish G, Karpati Z, Udvarhelyi I, Szigeti I, Bely M. Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice. Orthopedics. 1998;21(7):751-756.
28. Ochs BG, Muller-Horvat C, Albrecht D, et al. Remodeling of articular cartilage and subchondral bone after bone grafting and matrix-associated autologous chondrocyte implantation for osteochondritis dissecans of the knee. Am J Sports Med. 2011;39(4):764-773.
29. Kon E, Filardo G, Drobnic M, et al. Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2012;20(3): 436-449.
30. Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18(4): 476-499.
31. Cucchiarini M, Venkatesan JK, Ekici M, Schmitt G, Madry H. Human mesenchymal stem cells overexpressing therapeutic genes: from basic science to clinical applications for articular cartilage repair. Biomed Mater Eng. 2012;22(4):197-208.
32. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9(5): 641-650.
33. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411): 143-147.
34. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105(4):1815-1822.
35. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98(5):1076-1084.
36. Fong EL, Chan CK, Goodman SB. Stem cell homing in musculoskeletal injury. Biomaterials. 2011;32(2):395-409.
37. Liechty K W, MacKenzie TC, Shaaban A F, et al. Human mesenchymal stem cells engraft and demonstrate site-specifc differentiation after in utero transplantation in sheep. Nat Med. 2000;6(11):1282-1286.
38. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defn-ing multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4): 315-317.
39. Horwitz EM, Le Blanc K, Dominici M, et al. Clarifcation of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393-395.
40. Friedenstein AJ, Deriglasova UF, Kulagina NN, et al. Precursors for fbroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2(2): 83-92.
41. Mackay AM, Beck SC, Murphy JM, Barry F P, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mes-enchymal stem cells from marrow. Tissue Eng. 1998;4(4):415-428.
42. Yo o JU, Barthel TS, Nishimura K, et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am. 1998;80(12):1745-1757.
43. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25(6):1384-1392.
44. Al Faqeh H, Nor Hamdan BM, Chen HC, Aminuddin BS, Ruszymah BH. The potential of intra-articular injection of chondrogenic-induced bone marrow stem cells to retard the progression of osteoarthritis in a sheep model. Exp Gerontol. 2012;47(6):458-464.
45. Alfaqeh H, Norhamdan MY, Chua KH, Chen HC, Aminuddin BS, Ruszymah BH. Cell based therapy for osteoarthritis in a sheep model: gross and histological assessment. Med J Malaysia. 2008;63 Suppl A: 37-38.
46. Grigolo B, Lisignoli G, Desando G, et al. Osteoarthritis treated with mesenchymal stem cells on hyaluronan-based scaffold in rabbit. Tissue Eng Part C Methods. 2009;15(4):647-658.
47. Guo X, Wang C, Zhang Y, et al. Repair of large articular cartilage defects with implants of autologous mesenchymal stem cells seeded into beta-tricalcium phosphate in a sheep model. Tissue Eng. 2004; 10(11-12):1818-1829.
48. Im GI, Kim DY, Shin JH, Hyun C W, Cho WH. Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. J Bone Joint Surg Br. 2001;83(2):289-294.
49. Johnstone B, Yo O JU. Autologous mesenchymal progenitor cells in articular cartilage repair. Clin Orthop Relat Res. 1999;367 Suppl: S156-S162.
50. Jung M, Kaszap B, Redohl A, et al. Enhanced early tissue regeneration after matrix-assisted autologous mesenchymal stem cell transplantation in full thickness chondral defects in a minipig model. Cell Transplant. 2009;18(8):923-932.
51. Koga H, Muneta T, Nagase T, et al. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res. 2008;333(2):207-215.
52. Li Q, Tang J, Wang R, et al. Comparing the chondrogenic potential in vivo of autogeneic mesenchymal stem cells derived from different tissues. Artif Cells Blood Substit Immobil Biotechnol. 2011;39(1): 31-38.
53. McIlwraith C W, Frisbie DD, Rodkey WG, et al. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects. Arthroscopy. 2011;27(11):1552-1561.
54. Murphy JM, Fink DJ, Hunziker EB, Barry F P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. 2003;48(12): 3464-3474.
55. Nishimori M, Deie M, Kanaya A, Exham H, Adachi N, Ochi M. Repair of chronic osteochondral defects in the rat. A bone marrow-stimulating procedure enhanced by cultured allogenic bone marrow mesenchymal stromal cells. J Bone Joint Surg Br. 2006;88(9): 1236-1244.
56. Radice M, Brun P, Cortivo R, Scapinelli R, Battaliard C, Abatangelo G. Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors. J Biomed Mater Res. 2000;50(2): 101-109.
57. Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1994;76(4):579-592.
58. Wakitani S, Yamamoto T. Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defect. Microsc Res Tech. 2002;58(1):14-18.
59. Yan H, Yu C. Repair of full-thickness cartilage defects with cells of different origin in a rabbit model. Arthroscopy. 2007;23(2):178-187.
60. Harris PB. Being old: a confrontation group with nursing home residents. Health Soc Work. 1979;4(1):152-166.
61. Peng L, Jia Z, Yin X, et al. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells Dev. 2008;17(4):761-773.
62. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279-4295.
63. De Ugarte DA, Alfonso Z, Zuk PA, et al. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett. 2003;89(2-3): 267-270.
64. Diekman BO, Rowland CR, Lennon D P, Caplan AI, Guilak F. Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix. Tissue Eng Part A. 2010;16(2):523-533.
65. Hennig T, Lorenz H, Thiel A, et al. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profle and is overcome by BMP-6. J Cell Physiol. 2007;211(3):682-691.
66. Izadpanah R, Trygg C, Patel B, et al. Biologic properties of mesenchy-mal stem cells derived from bone marrow and adipose tissue. J Cell Biochem. 2006;99(5):1285-1297.
67. Rider DA, Dombrowski C, Sawyer AA, et al. Autocrine fbroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells. 2008;26(6):1598-1608.
68. Huang JI, Kazmi N, Durbhakula MM, Hering TM, Yoo JU, Johnstone B. Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res. 2005;23(6):1383-1389.
69. Cui L, Wu Y, Cen L, et al. Repair of articular cartilage defect in non-weight bearing areas using adipose derived stem cells loaded polygly-colic acid mesh. Biomaterials. 2009;30(14):2683-2693.
70. Desando G, Cavallo C, Sartoni F, et al. Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit model. Arthritis Res Ther. 2013;15(1):R22-R36.
71. Guercio A, Di Marco P, Casella S, et al. Production of canine mesen-chymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints. Cell Biol Int. 2012;36(2):189-194.
72. Jurgens WJ, Kroeze RJ, Zandieh-Doulabi B, et al. One-step surgical procedure for the treatment of osteochondral defects with adipose-derived stem cells in a caprine knee defect: a pilot study. Biores Open Access. 2013;2(4):315-325.
73. Masuoka K, Asazuma T, Hattori H, et al. Tissue engineering of articular cartilage with autologous cultured adipose tissue-derived stromal cells using atelocollagen honeycomb-shaped scaffold with a membrane sealing in rabbits. J Biomed Mater Res B Appl Biomater. 2006;79(1):25-34.
74. Nathan S, Das De S, Thambyah A, Fen C, Goh J, Lee EH. Cell-based therapy in the repair of osteochondral defects: a novel use for adipose tissue. Tissue Eng. 2003;9(4):733-744.
75. Oliveira JT, Gardel LS, Rada T, Martins L, Gomes ME, Reis RL. Injectable gellan gum hydrogels with autologous cells for the treatment of rabbit articular cartilage defects. J Orthop Res. 2010;28(9): 1193-1199.
76. ter Huurne M, Schelbergen R, Blattes R, et al. Antiinfammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum. 2012;64(11):3604-3613.
77. Toghraie F, Razmkhah M, Gholipour MA, et al. Scaffold-free adipose-derived stem cells (ASCs) improve experimentally induced osteoarthri-tis in rabbits. Arch Iran Med. 2012;15(8):495-499.
78. Toghraie FS, Chenari N, Gholipour MA, et al. Treatment of osteoarthri-tis with infrapatellar fat pad derived mesenchymal stem cells in rabbit. Knee. 2011;18(2):71-75.
79. De Bari C, Dell'Accio F, Tylzanowski P, Luyten F P. Multipotent mes-enchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001;44(8):1928-1942.
80. Fan J, Varshney RR, Ren L, Cai D, Wang DA. Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng Part B Rev. 2009;15(1):75-86.
81. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005;52(8):2521-2529.
82. Shirasawa S, Sekiya I, Sakaguchi Y, Yagishita K, Ichinose S, Muneta T. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem. 2006;97(1):84-97.
83. Koga H, Shimaya M, Muneta T, et al. Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect. Arthritis Res Ther. 2008;10(4):R84-R93.
84. Lee JC, Lee S Y, Min HJ, et al. Synovium-derived mesenchymal stem cells encapsulated in a novel injectable gel can repair osteochondral defects in a rabbit model. Tissue Eng Part A. 2012;18(19-20):2173-2186.
85. Lee JC, Min HJ, Park HJ, Lee S, Seong SC, Lee MC. Synovial membrane-derived mesenchymal stem cells supported by platelet-rich plasma can repair osteochondral defects in a rabbit model. Arthroscopy. 2013;29(6):1034-1046.
86. Nakamura T, Sekiya I, Muneta T, et al. Arthroscopic, histological and MRI analyses of cartilage repair after a minimally invasive method of transplantation of allogeneic synovial mesenchymal stromal cells into cartilage defects in pigs. Cytotherapy. 2012;14(3):327-338.
87. Shimomura K, Ando W, Tateishi K, et al. The infuence of skeletal maturity on allogenic synovial mesenchymal stem cell-based repair of cartilage in a large animal model. Biomaterials. 2010;31(31): 8004-8011.
88. Mara CS, Sartori AR, Duarte AS, Andrade AL, Pedro MA, Coimbra IB. Periosteum as a source of mesenchymal stem cells: the effects of TGF-beta3 on chondrogenesis. Clinics (Sao Paulo). 2011;66(3):487-492.
89. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294-1301.
90. Wakitani S, Yamamoto T. Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defect. Microsc Res Tech. 2002;58(1):14-18.
91. Hui JH, Li L, Teo YH, Ouyang H W, Lee EH. Comparative study of the ability of mesenchymal stem cells derived from bone marrow, periosteum, and adipose tissue in treatment of partial growth arrest in rabbit. Tissue Eng. 2005;11(5-6):904-912.
92. Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004;22(4):625-634.
93. Rosenbaum AJ, Grande DA, Dines JS. The use of mesenchymal stem cells in tissue engineering: a global assessment. Organogenesis. 2008;4(1):23-27.
94. Grande DA, Southerland SS, Manji R, Pate DW, Schwartz RE, Lucas PA. Repair of articular cartilage defects using mesenchymal stem cells. Tissue Eng. 1995;1(4):345-353.
95. Matsumoto T, Kubo S, Meszaros LB, et al. The infuence of sex on the chondrogenic potential of muscle-derived stem cells: implications for cartilage regeneration and repair. Arthritis Rheum. 2008;58(12):3809-3819.
96. Chong P P, Selvaratnam L, Abbas AA, Kamarul T. Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. J Orthop Res. 2012;30(4):634-642.
97. Korbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood. 2001;98(10):2900-2908.
98. Zvaifer NJ, Marinova-Mutafchieva L, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000;2(6):477-488.
99. Chang F, Ishii T, Yanai T, et al. Repair of large full-thickness articular cartilage defects by transplantation of autologous uncultured bone-marrow-derived mononuclear cells. J Orthop Res. 2008;26(1): 18-26.
100. Guzzo RM, Gibson J, Xu RH, Lee FY, Drissi H. Effcient differentiation of human iPSC-derived mesenchymal stem cells to chondropro-genitor cells. J Cell Biochem. 2013;114(2):480-490.
101. Hwang NS, Varghese S, Zhang Z, Elisseeff J. Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate-modifed hydrogels. Tissue Eng. 2006;12(9):2695-2706.
102. Koyama N, Miura M, Nakao K, et al. Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mes-enchymal progenitor cells. Stem Cells Dev. 2013;22(1):102-113.
103. Legg K. Stem cells: chondrogenesis induced from human embryonic stem cells. Nat Rev Rheumatol. 2010;6(2):66.
104. Oldershaw RA, Baxter MA, Lowe ET, et al. Directed differentiation of human embryonic stem cells toward chondrocytes. Nat Biotechnol. 2010;28(11):1187-1194.
105. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391): 1145-1147.
106. Vats A, Bielby RC, Tolley N, et al. Chondrogenic differentiation of human embryonic stem cells: the effect of the micro-environment. Tissue Eng. 2006;12(6):1687-1697.
107. Wei Y, Zeng W, Wan R, et al. Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix. Eur Cell Mater. 2012;23:1-12.
108. Dattena M, Pilichi S, Rocca S, et al. Sheep embryonic stem-like cells transplanted in full-thickness cartilage defects. J Tissue Eng Regen Med. 2009;3(3):175-187.
109. Hwang NS, Varghese S, Lee HJ, et al. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A. 2008;105(52): 20641-20646.
110. Toh WS, Lee EH, Guo XM, et al. Cartilage repair using hyaluronan hydrogel-encapsulated human embryonic stem cell-derived chondro-genic cells. Biomaterials. 2010;31(27):6968-6980.
111. Olee T, Grogan S P, Lotz M, Colwell CW Jr, Snyder E, D'Lima D. Repair of cartilage defects in arthritic tissue with differentiated human embryonic stem cells. Tissue Eng Part A. October 19, 2013. [Epub ahead of print.]
112. Blum B, Benvenisty N. Clonal analysis of human embryonic stem cell differentiation into teratomas. Stem Cells. 2007;25(8): 1924-1930.
113. Hou P, Li Y, Zhang X, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science. 2013;341(6146): 651-654.
114. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fbroblasts by defned factors. Cell. 2007;131(5):861-872.
115. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell. 2006;126(4):663-676.
116. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858): 1917-1920.
117. Diekman BO, Christoforou N, Willard V P, et al. Cartilage tissue engineering using differentiated and purifed induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012;109(47):19172-19177.
118. Kim MJ, Son MJ, Son M Y, et al. Generation of human induced pluri-potent stem cells from osteoarthritis patient-derived synovial cells. Arthritis Rheum. 2011;63(10):3010-3021.
119. Shafa M, Sjonnesen K, Yamashita A, et al. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors. J Tissue Eng Regen Med. 2012;6(6):462-472.
120. Yamashita A, Liu S, Woltjen K, et al. Cartilage tissue engineering identifes abnormal human induced pluripotent stem cells. Sci Rep. 2013;3:1978-1983.
121. Frenkel SR, Toolan B, Menche D, Pitman MI, Pachence JM. Chondrocyte transplantation using a collagen bilayer matrix for cartilage repair. J Bone Joint Surg Br. 1997;79(5):831-836.
122. Iwasa J, Engebretsen L, Shima Y, Ochi M. Clinical application of scaffolds for cartilage tissue engineering. Knee Surg Sports Traumatol Arthrosc. 2009;17(6):561-577.
123. Ho W, Tawil B, Dunn JC, Wu BM. The behavior of human mesenchy-mal stem cells in 3D fbrin clots: dependence on fbrinogen concentration and clot structure. Tissue Eng. 2006;12(6):1587-1595.
124. Tognana E, Borrione A, De Luca C, Pavesio A. Hyalograft C: hyaluronan-based scaffolds in tissue-engineered cartilage. Cells Tissues Organs. 2007;186(2):97-103.
125. Toole B P. Hyaluronan in morphogenesis. Semin Cell Dev Biol. 2001;12(2):79-87.
126. Glowacki J, Mizuno S. Collagen scaffolds for tissue engineering. Biopolymers. 2008;89(5):338-344.
127. Guo X, Wang C, Duan C, et al. Repair of osteochondral defects with autologous chondrocytes seeded onto bioceramic scaffold in sheep. Tissue Eng. 2004;10(11-12):1830-1840.
128. Kandel RA, Grynpas M, Pilliar R, et al. Repair of osteochondral defects with biphasic cartilage-calcium polyphosphate constructs in a sheep model. Biomaterials. 2006;27(22):4120-4131.
129. Chen J, Chen H, Li P, et al. Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds. Biomaterials. 2011;32(21):4793-4805.
130. Fan H, Hu Y, Zhang C, et al. Cartilage regeneration using mesenchy-mal stem cells and a PLGA-gelatin/chondroitin/hyaluronate hybrid scaffold. Biomaterials. 2006;27(26):4573-4580.
131. Gao J, Dennis JE, Solchaga LA, Goldberg VM, Caplan AI. Repair of osteochondral defect with tissue-engineered two-phase composite material of injectable calcium phosphate and hyaluronan sponge. Tissue Eng. 2002;8(5):827-837.
132. Qi Y, Du Y, Li W, Dai X, Zhao T, Yan W. Cartilage repair using mesenchymal stem cell (MSC) sheet and MSCs-loaded bilayer PLGA scaffold in a rabbit model. Knee Surg Sports Traumatol Arthrosc. October 30, 2012. [Epub ahead of print.]
133. Shao XX, Hutmacher DW, Ho ST, Goh JC, Lee EH. Evaluation of a hybrid scaffold/cell construct in repair of high-load-bearing osteochondral defects in rabbits. Biomaterials. 2006;27(7): 1071-1080.
134. Zscharnack M, Hepp P, Richter R, et al. Repair of chronic osteochon-dral defects using predifferentiated mesenchymal stem cells in an ovine model. Am J Sports Med. 2010;38(9):1857-1869.
135. Daher RJ, Chahine NO, Greenberg AS, Sgaglione NA, Grande DA. New methods to diagnose and treat cartilage degeneration. Nat Rev Rheumatol. 2009;5(11):599-607.
136. Johnstone B, Alini M, Cucchiarini M, et al. Tissue engineering for articular cartilage repair - the state of the art. Eur Cell Mater. 2013;25:248-267.
137. Madry H, Rey-Rico A, Venkatesan JK, Johnstone B, Cucchiarini M. Transforming growth factor beta-releasing scaffolds for cartilage tissue engineering. Tissue Eng Part B Rev. August 12, 2013. [Epub ahead of print.]
138. Madry H, Cucchiarini M. Advances and challenges in gene-based approaches for osteoarthritis. J Gene Med. 2013;15(10):343-355.
139. Diao H, Wang J, Shen C, et al. Improved cartilage regeneration utilizing mesenchymal stem cells in TGF-beta1 gene-activated scaffolds. Tissue Eng Part A. 2009;15(9):2687-2698.
140. He CX, Zhang TY, Miao PH, et al. TGF-beta1 gene-engineered mes-enchymal stem cells induce rat cartilage regeneration using nonviral gene vector. Biotechnol Appl Biochem. 2012;59(3):163-169.
141. Im GI, Lee JH. Repair of osteochondral defects with adipose stem cells and a dual growth factor-releasing scaffold in rabbits. J Biomed Mater Res B Appl Biomater. 2010;92(2):552-560.
142. Ivkovic A, Pascher A, Hudetz D, et al. Articular cartilage repair by genetically modifed bone marrow aspirate in sheep. Gene Ther. 2010;17(6):779-789.
143. Lee JM, Kim BS, Lee H, Im GI. In vivo tracking of mesechymal stem cells using fuorescent nanoparticles in an osteochondral repair model. Mol Ther. 2012;20(7):1434-1442.
144. Li B, Yang J, Ma L, Li F, Tu Z, Gao C. Fabrication of poly(lactide-co-glycolide) scaffold flled with fbrin gel, mesenchymal stem cells, and poly(ethylene oxide)-b-poly(L-lysine)/TGF-beta1 plasmid DNA complexes for cartilage restoration in vivo. J Biomed Mater Res A. 2013;101(11):3097-3108.
145. Li B, Yang J, Ma L, Li F, Tu Z, Gao C. Infuence of the molecular weight of poly(lactide-co-glycolide) on the in vivo cartilage repair by a construct of poly(lactide-co-glycolide)/fbrin gel/mesenchymal stem cells/transforming growth factor-beta1. Tissue Eng Part A. September 17, 2013. [Epub ahead of print.]
146. Miller RE, Grodzinsky AJ, Vanderploeg EJ, et al. Effect of self-assembling peptide, chondrogenic factors, and bone marrow-derived stromal cells on osteochondral repair. Osteoarthritis Cartilage. 2010;18(12):1608-1619.
147. Mrugala D, Bony C, Neves N, et al. Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model. Ann Rheum Dis. 2008;67(3):288-295.
148. Pagnotto MR, Wang Z, Karpie JC, Ferretti M, Xiao X, Chu CR. Adeno-associated viral gene transfer of transforming growth factor-beta1 to human mesenchymal stem cells improves cartilage repair. Gene Ther. 2007;14(10):804-813.
149. Park JS, Woo DG, Yang HN, et al. Chondrogenesis of human mesen-chymal stem cells encapsulated in a hydrogel construct: neocartilage formation in animal models as both mice and rabbits. J Biomed Mater Res A. 2010;92(3):988-996.
150. Qi B W, Yu AX, Zhu SB, Zhou M, Wu G. Chitosan/poly(vinyl alcohol) hydrogel combined with Ad-hTGF-beta1 transfected mesenchymal stem cells to repair rabbit articular cartilage defects. Exp Biol Med (Maywood). 2013;238(1):23-30.
151. Wang W, Li B, Li Y, Jiang Y, Ouyang H, Gao C. In vivo restoration of full-thickness cartilage defects by poly(lactide-co-glycolide) sponges flled with fbrin gel, bone marrow mesenchymal stem cells and DNA complexes. Biomaterials. 2010;31(23):5953-5965.
152. Wu G, Cui Y, Ma L, Pan X, Wang X, Zhang B. Repairing cartilage defects with bone marrow mesenchymal stem cells induced by CDMP and TGF-beta. Cell Tissue Bank. March 5, 2013. [Epub ahead of print.]
153. Kubo S, Cooper GM, Matsumoto T, et al. Blocking vascular endothe-lial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Arthritis Rheum. 2009;60(1):155-165.
154. Kuroda R, Usas A, Kubo S, et al. Cartilage repair using bone mor-phogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum. 2006;54(2):433-442.
155. Matsumoto T, Cooper GM, Gharaibeh B, et al. Blocking VEGF as a potential approach to improve cartilage healing after osteoarthritis. J Musculoskelet Neuronal Interact. 2008;8(4):316-317.
156. Matsumoto T, Cooper GM, Gharaibeh B, et al. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum. 2009;60(5):1390-1405.
157. Mifune Y, Matsumoto T, Takayama K, et al. The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair. Osteoarthritis Cartilage. 2013;21(1): 175-185.
158. Park J, Gelse K, Frank S, von der Mark K, Aigner T, Schneider H. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum-and fat-derived cells. J Gene Med. 2006;8(1):112-125.
159. Reyes R, Pec MK, Sanchez E, del Rosario C, Delgado A, Evora C. Comparative, osteochondral defect repair: stem cells versus chondro-cytes versus bone morphogenetic protein-2, solely or in combination. Eur Cell Mater. 2013;25:351-365.
160. Katayama R, Wakitani S, Tsumaki N, et al. Repair of articular cartilage defects in rabbits using CDMP1 gene-transfected autologous mesen-chymal cells derived from bone marrow. Rheumatology (Oxford). 2004;43(8):980-985.
161. Zhu S, Zhang B, Man C, Ma Y, Liu X, Hu J. Combined effects of connective tissue growth factor-modifed bone marrow-derived mes-enchymal stem cells and NaOH-treated PLGA scaffolds on repair of articular cartilage defect in rabbits. Cell Transplant. July 11, 2013. [Epub ahead of print.]
162. Cao L, Yang F, Liu G, et al. The promotion of cartilage defect repair using adenovirus mediated Sox9 gene transfer of rabbit bone marrow mesenchymal stem cells. Biomaterials. 2011;32(16):3910-3920.
163. Im GI, Kim HJ, Lee JH. Chondrogenesis of adipose stem cells in a porous PLGA scaffold impregnated with plasmid DNA containing SOX trio (SOX-5,-6 and -9) genes. Biomaterials. 2011;32(19): 4385-4392.
164. Lee JM, Im GI. SOX trio-co-transduced adipose stem cells in fbrin gel to enhance cartilage repair and delay the progression of osteoarthritis in the rat. Biomaterials. 2012;33(7):2016-2024.
165. Liu TM, Guo XM, Tan HS, Hui JH, Lim B, Lee EH. Zinc-fnger protein 145, acting as an upstream regulator of SOX9, improves the differentiation potential of human mesenchymal stem cells for cartilage regeneration and repair. Arthritis Rheum. 2011;63(9): 2711-2720.
166. Hu B, Ren JL, Zhang JR, Ma Q, Liu Y P, Mao TQ. Enhanced treatment of articular cartilage defect of the knee by intra-articular injection of Bcl-xL-engineered mesenchymal stem cells in rabbit model. J Tissue Eng Regen Med. 2010;4(2):105-114.
167. Fan H, Hu Y, Qin L, Li X, Wu H, Lv R. Porous gelatin-chondroitin-hyaluronate tri-copolymer scaffold containing microspheres loaded with TGF-beta1 induces differentiation of mesenchymal stem cells in vivo for enhancing cartilage repair. J Biomed Mater Res A. 2006;77(4): 785-794.
168. Little CB, Zaki S. What constitutes an "animal model of osteoar-thritis" - the need for consensus? Osteoarthritis Cartilage. 2012;20(4):261-267.
169. Poole R, Blake S, Buschmann M, et al. Recommendations for the use of preclinical models in the study and treatment of osteoarthritis. Osteoarthritis Cartilage. 2010;18 Suppl 3:S10-S16.
170. Evans CH, Ghivizzani SC, Robbins PD. Arthritis gene therapy's frst death. Arthritis Res Ther. 2008;10(3):110-118.
171. Brand C. Intra-articular and soft tissue injections. Aust Fam Physician. 1990;19(5):671-675, 678, 680-672.
172. Cardone DA, Tallia AF. Diagnostic and therapeutic injection of the hip and knee. Am Fam Physician. 2003;67(10):2147-2152.
173. Courtney P, Doherty M. Joint aspiration and injection. Best Pract Res Clin Rheumatol. 2005;19(3):345-369.
174. Courtney P, Doherty M. Joint aspiration and injection and synovial fuid analysis. Best Pract Res Clin Rheumatol. 2009;23(2):161-192.
175. Courtney P, Doherty M. Joint aspiration and injection and synovial fuid analysis. Best Pract Res Clin Rheumatol. 2013;27(2):137-169.
176. Lockman LE. Practice tips. Knee joint injections and aspirations: the triangle technique. Can Fam Physician. 2006;52(11):1403-1404.
177. Pfenninger JL. Injections of joints and soft tissue: Part II. Guidelines for specifc joints. Am Fam Physician. 1991;44(5):1690-1701.
178. Wittich CM, Ficalora RD, Mason TG, Beckman TJ. Musculoskeletal injection. Mayo Clin Proc. 2009;84(9):831-836.
179. Bathis H, Perlick L, Blum C, Luring C, Perlick C, Grifka J. Midvastus approach in total knee arthroplasty: a randomized, double-blinded study on early rehabilitation. Knee Surg Sports Traumatol Arthrosc. 2005;13(7):545-550.
180. Bridgman S, Walley G, MacKenzie G, Clement D, Griffiths D, Maffulli N. Sub-vastus approach versus the medial parapatel-lar approach in primary total knee: a randomised controlled trial [ISRCTN44544446]. Trials. 2006;7:23-29.
181. Engh GA, Parks NL. Surgical technique of the midvastus arthrotomy. Clin Orthop Relat Res. 1998(351):270-274.
182. Floren M, Reichel H, Davis J, Laskin RS. The mini-incision mid-vastus approach for total knee arthroplasty. Oper Orthop Traumatol. 2008;20(6):534-543.
183. Frosch KH, Voss M, Walde T, et al. A minimally invasive dorsal approach to the medial femoral condyle as a donor site for osteochondral transfer procedures. Oper Orthop Traumatol. 2010;22(2):212-220.
184. Maestro A, Suarez MA, Rodriguez L, Guerra C, Murcia A. The midvastus surgical approach in total knee arthroplasty. Int Orthop. 2000;24(2):104-107.
185. Tenholder M, Clarke HD, Scuderi GR. Minimal-incision total knee arthroplasty: the early clinical experience. Clin Orthop Relat Res. 2005;440:67-76.
186. Tria AJ Jr. Minimally invasive total knee arthroplasty: past, present, and future. Am J Orthop (Belle Mead NJ). 2007;36(Suppl 9):6-7.
187. Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA. 1989;262(7): 925-930.
188. Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Med. 1969;62(10):989-993.
189. Hefti F, Muller W, Jakob R P, Staubli HU. Evaluation of knee ligament injuries with the IKDC form. Knee Surg Sports Traumatol Arthrosc. 1993;1(3-4):226-234.
190. Irrgang JJ, Anderson AF, Boland AL, et al. Development and validation of the international knee documentation committee subjective knee form. Am J Sports Med. 2001;29(5):600-613.
191. Lysholm J, Gillquist J. Evaluation of knee ligament surgery results with special emphasis on use of a scoring scale. Am J Sports Med. 1982;10(3):150-154.
192. Roos EM, Roos H P, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS) - development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28(2):88-96.
193. Ranawat CS, Shine JJ. Duo-condylar total knee arthroplasty. Clin Orthop Relat Res. 1973(94):185-195.
194. Bellamy N, Buchanan W W, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833-1840.
195. Lee KB, Wang VT, Chan YH, Hui JH. A novel, minimally-invasive technique of cartilage repair in the human knee using arthroscopic microfracture and injections of mesenchymal stem cells and hyaluronic acid - a prospective comparative study on safety and short-term effcacy. Ann Acad Med Singapore. 2012;41(11):511-517.
196. Saw KY, Anz A, Merican S, et al. Articular cartilage regeneration with autologous peripheral blood progenitor cells and hyaluronic acid after arthroscopic subchondral drilling: a report of 5 cases with histology. Arthroscopy. 2011;27(4):493-506.
197. Saw KY, Anz A, Siew-Yoke Jee C, et al. Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial. Arthroscopy. 2013;29(4): 684-694.
198. Skowronski J, Skowronski R, Rutka M. Cartilage lesions of the knee treated with blood mesenchymal stem cells - results. Ortop Traumatol Rehabil. 2012;14(6):569-577.
199. Adachi N, Ochi M, Deie M, Ito Y. Transplant of mesenchymal stem cells and hydroxyapatite ceramics to treat severe osteochondral damage after septic arthritis of the knee. J Rheumatol. 2005;32(8): 1615-1618.
200. Buda R, Vannini F, Cavallo M, Grigolo B, Cenacchi A, Giannini S. Osteochondral lesions of the knee: a new one-step repair technique with bone-marrow-derived cells. J Bone Joint Surg Am. 2010;92 Suppl 2: 2-11.
201. Gigante A, Calcagno S, Cecconi S, Ramazzotti D, Manzotti S, Enea D. Use of collagen scaffold and autologous bone marrow concentrate as a one-step cartilage repair in the knee: histological results of second-look biopsies at 1 year follow-up. Int J Immunopathol Pharmacol. 2011;24(1 Suppl 2):69-72.
202. Haleem AM, Singergy AA, Sabry D, et al. The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fbrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage. 2010;1(4):253-261.
203. Kasemkijwattana C, Hongeng S, Kesprayura S, Rungsinaporn V, Chaipinyo K, Chansiri K. Autologous bone marrow mesenchymal stem cells implantation for cartilage defects: two cases report. J Med Assoc Thai. 2011;94(3):395-400.
204. Kuroda R, Ishida K, Matsumoto T, et al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage. 2007;15(2):226-231.
205. Nejadnik H, Hui JH, Feng Choong E P, Tai BC, Lee EH. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010;38(6):1110-1116.
206. Skowronski J, Rutka M. Osteochondral lesions of the knee reconstructed with mesenchymal stem cells - results. Ortop Traumatol Rehabil. 2013;15(3):195-204.
207. Skowronski J, Skowronski R, Rutka M. Large cartilage lesions of the knee treated with bone marrow concentrate and collagen membrane - results. Ortop Traumatol Rehabil. 2013;15(1): 69-76.
208. Slynarski K, Deszczynski J, Karpinski J. Fresh bone marrow and periosteum transplantation for cartilage defects of the knee. Transplant Proc. 2006;38(1):318-319.
209. Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant. 2004;13(5):595-600.
210. Wakitani S, Nawata M, Tensho K, Okabe T, Machida H, Ohgushi H. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in fve knees. J Tissue Eng Regen Med. 2007;1(1):74-79.
211. Oslo University Hospital. Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects. Available from: http://clinicaltrials.gov/show/NCT00885729. NLM identifer: NCT00885729. Accessed December 19, 2014.
212. Cairo University. The Use of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Articular Cartilage Defects. Available from: http://clinicaltrials.gov/show/NCT00891501. NLM identifer: NCT00891501. Accessed December 19, 2013.
213. Royan Institute. Autologous Transplantation of Mesenchymal Stem Cells (MSCs) and Scaffold in Full-thickness Articular Cartilage. Available from: http://clinicaltrials.gov/show/NCT00850187. NLM identifer: NCT00850187. Accessed December 19, 2013.
214. Michel Assor, MD. Transplantation of Bone Marrow Stem Cells Stimulated by Proteins Scaffold to Heal Defects Articular Cartilage of the Knee. Available from: http://clinicaltrials.gov/show/NCT01159899. NLM identifer: NCT01159899. Accessed December 19, 2013.
215. Fundacion para la InvestigacionBiomedicadel Hospital Universitario la Paz. Autologous Mesenchymal Stem Cells vs. Chondrocytes for the Repair of Chondral Knee Defects (ASCROD). Available from: http://clinicaltrials.gov/show/NCT01399749. NLM identifer: NCT01399749. Accessed December 19, 2013.
216. Medipost Co Ltd. Study to Compare the Effcacy and Safety of Cartistem® and Microfracture in Patients With Knee Articular Cartilage Injury or Defect. Available from: http://clinicaltrials.gov/show/NCT01041001. NLM identifer: NCT01041001. Accessed December 19, 2013.
217. Medipost Co Ltd. Follow-Up Study of CARTISTEM® Versus Micro-fracture for the Treatment of Knee Articular Cartilage Injury or Defect. Available from: http://clinicaltrials.gov/show/NCT01626677. NLM identifer: NCT01626677. Accessed December 19, 2013.
218. Medipost Co Ltd. Evaluation of Safety and Exploratory Effcacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects. Available from: http://clinicaltrials.gov/show/NCT01733186. NLM identifer: NCT01733186. Accessed December 19, 2013.
219. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008;11(3):343-353.
220. Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis. 2011;14(2):211-215.
221. Emadedin M, Aghdami N, Taghiyar L, et al. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med. 2012;15(7):422-428.
222. Orozco L, Munar A, Soler R, et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation. 2013;95(12):1535-1541.
223. Varma HS, Dadarya B, Vidyarthi A. The new avenues in the management of osteo-arthritis of knee - stem cells. J Indian Med Assoc. 2010;108(9):583-585.
224. Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19(6):902-907.
225. Koh YG, Jo SB, Kwon OR, et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy. 2013;29(4): 748-755.
226. Pak J. Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series. J Med Case Rep. 2011;5:296-303.
227. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage. 2002;10(3):199-206.
228. International Stemcell Services Limited. Safety and Effcacy of Autolo-gous Bone Marrow Stem Cells for Treating Osteoarthritis. Available from: http://clinicaltrials.gov/show/NCT01152125. NLM identifer: NCT01152125. Accessed December 19, 2013.
229. Hospital Universitario Dr. Jose E. Gonzalez. Autologous Stem Cells in Osteoarthritis. Available from: http://clinicaltrials.gov/show/NCT01485198. NLM identifer: NCT01485198. Accessed December 19, 2013.
230. Paulo Brofman. Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair. Available from: http://www.clinicaltrials.gov/ct2/show/NCT01895413. NLM identifer: NCT01895413. Accessed December 19, 2013.
231. Mayo Clinic. Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis (BMAC). Available from: http://clinicaltrials.gov/ct2/show/NCT01931007. NLM identifer: NCT01931007. Accessed December 19, 2013.
232. Nantes University Hospital. Regenerative Medicine of Articular Cartilage: Characterization and Comparison of Chondrogenic Potential and Immunomodulatory Adult Mesenchymal Stem Cells (ARTHROSTEM). Available from: http://clinicaltrials.gov/ct2/show/NCT01879046. NLM identifer: NCT01879046. Accessed December 19, 2013.
233. Stempeutics Research Pvt Ltd. Allogeneic Mesenchymal Stem Cells for Osteoarthritis. Available from: http://clinicaltrials.gov/show/NCT01448434. NLM identifer: NCT01448434. Accessed December 19, 2013.
234. Stempeutics Research Pvt Ltd. Allogeneic Mesenchymal Stem Cells in Osteoarthritis. Available from: http://clinicaltrials.gov/show/NCT01453738. NLM identifer: NCT01453738. Accessed December 19, 2013.
235. National University of Malaysia. Intra-Articular Autologous Bone Marrow Mesenchymal Stem Cells Transplantation to Treat Mild to Moderate Osteoarthritis. Available from: http://clinicaltrials.gov/show/NCT01459640. NLM identifer: NCT01459640. Accessed December 19, 2013.
236. RNL Bio Company Ltd. Autologous Adipose Tissue Derived Mes-enchymal Stem Cells Transplantation in Patient With Degenerative Arthritis. Available from: http://clinicaltrials.gov/show/NCT01300598. NLM identifer: NCT01300598. Accessed December 19, 2013.
237. University Hospital, Montpellier. ADIPOA - Clinical Study. Available from: http://clinicaltrials.gov/show/NCT01585857. NLM identifer: NCT01585857. Accessed December 19, 2013.
238. Ageless Regenerative Institute. Autologous Adipose-Derived Stromal Cells Delivered Intra-articularly in Patients With Osteoarthritis. Available from: http://clinicaltrials.gov/show/NCT01739504. NLM identifer: NCT01739504. Accessed December 19, 2013.
239. Cellular Biomedicine Group Ltd. Autologous Adipose Tissue Derived Mesenchymal Progenitor Cells Therapy for Patients With Knee Osteoarthritis. Available from: http://clinicaltrials.gov/show/NCT01809769. NLM identifer: NCT01809769. Accessed December 19, 2013.
240. Translational Biosciences. Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis. Available from: http://clinicaltrials.gov/show/NCT01885832. NLM identifer: NCT01885832. Accessed December 19, 2013.
241. Institute of Regenerative and Cellular Medicine. Safety and Clinical Effectiveness of A3 SVF in Osteoarthritis. Available from: http://www.clinicaltrials.gov/show/NCT01947348. NLM identifier: NCT01947348. Accessed December 19, 2013.